R
Robert E. Glasgow
Researcher at University of Utah
Publications - 68
Citations - 4023
Robert E. Glasgow is an academic researcher from University of Utah. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 20, co-authored 67 publications receiving 3130 citations. Previous affiliations of Robert E. Glasgow include National Institutes of Health & Huntsman Cancer Institute.
Papers
More filters
Journal ArticleDOI
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A. Ajani,Thomas A. D'Amico,David J. Bentrem,Joseph Chao,Carlos U. Corvera,Prajnan Das,Crystal S. Denlinger,Peter C. Enzinger,Paul T. Fanta,Farhood Farjah,Hans Gerdes,Michael Gibson,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kimberly L. Johung,Rajesh N. Keswani,Lawrence Kleinberg,Stephen Leong,Quan P. Ly,Kristina A. Matkowskyj,Michael McNamara,Mary F. Mulcahy,Ravi Kumar Paluri,Haeseong Park,Kyle A. Perry,Jose M. Pimiento,George A. Poultsides,Robert E. Roses,Vivian E. Strong,Georgia L. Wiesner,Christopher G. Willett,Cameron D. Wright,Nicole R. McMillian,Lenora A. Pluchino +37 more
TL;DR: This selection from the NCCN Guidelines for Esophageal and Esophagogastric Junction Cancers focuses on recommendations for the management of locally advanced and metastatic adenocarcinoma of the esophagus and EGJ.
Journal ArticleDOI
Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology
Jaffer A. Ajani,Thomas A. D'Amico,Khaldoun Almhanna,David J. Bentrem,Joseph Chao,Prajnan Das,Crystal S. Denlinger,Paul T. Fanta,Farhood Farjah,Charles S. Fuchs,Hans Gerdes,Michael K. Gibson,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kimberly L. Johung,Rajesh N. Keswani,Lawrence Kleinberg,W. Michael Korn,Stephen Leong,Catherine Linn,A. Craig Lockhart,Quan P. Ly,Mary F. Mulcahy,Mark B. Orringer,Kyle A. Perry,George A. Poultsides,Walter J. Scott,Vivian E. Strong,Mary Kay Washington,Benny Weksler,Christopher G. Willett,Cameron D. Wright,Debra Zelman,Nicole R. McMillian,Hema Sundar +38 more
TL;DR: The recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease are discussed.
Journal ArticleDOI
Gastric Cancer, Version 2.2013
Jaffer A. Ajani,David J. Bentrem,Stephen Besh,Thomas A. D'Amico,Prajnan Das,Crystal S. Denlinger,Marwan Fakih,Charles S. Fuchs,Hans Gerdes,Robert E. Glasgow,James A. Hayman,James A. Hayman,Wayne L. Hofstetter,David H. Ilson,Rajesh N. Keswani,Lawrence Kleinberg,Lawrence Kleinberg,W. Michael Korn,A. Craig Lockhart,Kenneth L. Meredith,Mary F. Mulcahy,Mark B. Orringer,Mark B. Orringer,James Posey,Aaron R. Sasson,Walter J. Scott,Vivian E. Strong,Thomas K. Varghese,Graham W. Warren,Mary Kay Washington,Christopher G. Willett,Cameron D. Wright,Nicole R. McMillian,Hema Sundar +33 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer provide evidence- and consensus-based recommendations for a multidisciplinary approach for the management of patients with gastric cancer.
Journal ArticleDOI
Esophageal and esophagogastric junction cancers, version 1.2015.
Jaffer A. Ajani,Thomas A. D'Amico,Khaldoun Almhanna,David J. Bentrem,Stephen Besh,Joseph Chao,Prajnan Das,Crystal S. Denlinger,Paul T. Fanta,Charles S. Fuchs,Hans Gerdes,Robert E. Glasgow,James A. Hayman,Steven N. Hochwald,Wayne L. Hofstetter,David H. Ilson,Dawn E. Jaroszewski,Kory Jasperson,Rajesh N. Keswani,Lawrence Kleinberg,W. Michael Korn,Stephen Leong,A. Craig Lockhart,Mary F. Mulcahy,Mark B. Orringer,James Posey,George A. Poultsides,Aaron R. Sasson,Walter J. Scott,Vivian E. Strong,Thomas K. Varghese,Mary Kay Washington,Christopher G. Willett,Cameron D. Wright,Debra Zelman,Nicole R. McMillian,Hema Sundar +36 more
TL;DR: This portion of the NCCN Guidelines for Esophageal and EGJ Cancers discusses management of locally advanced adenocarcinoma of the esophagus andEGJ.
Journal ArticleDOI
Esophageal and Esophagogastric Junction Cancers
Jaffer A. Ajani,James S. Barthel,David J. Bentrem,Thomas A. D'Amico,Prajnan Das,Crystal S. Denlinger,Charles S. Fuchs,Hans Gerdes,Robert E. Glasgow,James A. Hayman,Wayne L. Hofstetter,David H. Ilson,Rajesh N. Keswani,Lawrence Kleinberg,W. Michael Korn,A. Craig Lockhart,Mary F. Mulcahy,Mark B. Orringer,Raymond U. Osarogiagbon,James Posey,Aaron R. Sasson,Walter J. Scott,Stephen Shibata,Vivian E. Strong,Thomas K. Varghese,Graham W. Warren,Mary Kay Washington,Christopher G. Willett,Cameron D. Wright +28 more
TL;DR: A dramatic shift in the location of upper gastrointestinal tumors has occurred in the United States, and the number of new cases and deaths from upper gastrointestinal cancers has increased.